Meckler Jeffrey A

Co-Chief Executive Officer at Indaptus Therapeutics, Inc. · on record since Sep 16, 2021
10% owner at Indaptus Therapeutics, Inc. · on record since Dec 29, 2025
See Explanation of Responses at SURMODICS INC · on record since Dec 3, 2010
Director at NOVELION THERAPEUTICS INC. · on record since Jun 13, 2012
Director at Travere Therapeutics, Inc. · on record since May 6, 2026
Director at Cocrystal Pharma, Inc. · on record since Dec 15, 2014
CHIEF EXECUTIVE OFFICER at Cocrystal Pharma, Inc. · on record since Dec 28, 2015
Director at Intec Pharma Ltd. · on record since Jan 2, 2019
Chief Executive Officer at Intec Pharma Ltd. · on record since Jan 2, 2019
Director at Indaptus Therapeutics, Inc. · on record since Sep 16, 2021

Insider trading activity of Meckler Jeffrey A

Transactions on record: 109; since Jul 12, 2012

Open-market buys: 22; $1.4M

Open-market sells: 6; $2.3M

Companies traded: 5; last filing Sep 11, 2026

Figures computed from official regulatory filings — .

Companies where Meckler Jeffrey A has traded

Travere Therapeutics, Inc.43 tx · $3.6M · Sep 11, 2026
Indaptus Therapeutics, Inc.32 tx · $1.3M · Feb 13, 2026
Intec Pharma Ltd.4 tx · $59.6K · Jul 17, 2020
NOVELION THERAPEUTICS INC.22 tx · $449.1K · Jun 21, 2016
Cocrystal Pharma, Inc.8 tx · $403.5K · Mar 17, 2016

Track record of Meckler Jeffrey A

Statistical track record

Free account

Open-market buys: 22

Last buy: Nov 21, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Meckler Jeffrey A

Co-insiders of Meckler Jeffrey A

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Sell	-14,000	67.46 USD	$944.5K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Sell	-1,200	66.15 USD	$79.4K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Exercise	10,000	26.52 USD	$265.2K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Sell	-1,700	65.39 USD	$111.2K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Exercise	10,000	17.44 USD	$174.4K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Sell	-3,100	68.09 USD	$211.1K		SEC
Travere Therapeutics, Inc.Listing on record	May 21, 2026	Award	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	May 21, 2026	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	May 6, 2026	ExerciseD (derivative)	-8,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	May 6, 2026	Exercise	8,000	16.33 USD	$130.6K		SEC
Travere Therapeutics, Inc.Listing on record	May 6, 2026	Sell	-8,000	45.00 USD	$360K		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-1,519	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-12,136	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	AwardD (derivative)	1,519	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	AwardD (derivative)	3,033	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-3,033	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	AwardD (derivative)	12,136	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Dec 29, 2025	Award	216,617	2.03 USD	$439.7K	Unusual size	SEC
Indaptus Therapeutics, Inc.Listing on record	Jul 29, 2025	AwardD (derivative)	12,136	8.30 USD	$100.7K		SEC
Indaptus Therapeutics, Inc.Listing on record	Jul 29, 2025	Award	6,068	8.30 USD	$50.4K		SEC
Travere Therapeutics, Inc.Listing on record	May 16, 2025	Award	6,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	May 16, 2025	AwardD (derivative)	19,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Indaptus Therapeutics, Inc.Listing on record	Apr 11, 2025	OtherD (derivative)	-1,563	0.04 USD	$62.5		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Sell	-14,000	67.46 USD	$944.5K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Sell	-1,200	66.15 USD	$79.4K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Exercise	10,000	26.52 USD	$265.2K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Sell	-1,700	65.39 USD	$111.2K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Exercise	10,000	17.44 USD	$174.4K		SEC
Travere Therapeutics, Inc.Listing on record	Sep 11, 2026	Sell	-3,100	68.09 USD	$211.1K		SEC
Travere Therapeutics, Inc.Listing on record	May 21, 2026	Award	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	May 21, 2026	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	May 6, 2026	ExerciseD (derivative)	-8,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	May 6, 2026	Exercise	8,000	16.33 USD	$130.6K		SEC
Travere Therapeutics, Inc.Listing on record	May 6, 2026	Sell	-8,000	45.00 USD	$360K		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-1,519	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-12,136	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	AwardD (derivative)	1,519	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	AwardD (derivative)	3,033	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-3,033	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Feb 13, 2026	AwardD (derivative)	12,136	—	n/a (No price was disclosed in the filing)		SEC
Indaptus Therapeutics, Inc.Listing on record	Dec 29, 2025	Award	216,617	2.03 USD	$439.7K	Unusual size	SEC
Indaptus Therapeutics, Inc.Listing on record	Jul 29, 2025	AwardD (derivative)	12,136	8.30 USD	$100.7K		SEC
Indaptus Therapeutics, Inc.Listing on record	Jul 29, 2025	Award	6,068	8.30 USD	$50.4K		SEC
Travere Therapeutics, Inc.Listing on record	May 16, 2025	Award	6,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Travere Therapeutics, Inc.Listing on record	May 16, 2025	AwardD (derivative)	19,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Indaptus Therapeutics, Inc.Listing on record	Apr 11, 2025	OtherD (derivative)	-1,563	0.04 USD	$62.5		SEC